Traitement anticancéreux et modulation du système immunitaire

Traitement anticancéreux et modulation du système immunitaire

Les thérapies anticancéreuses ont apporté un gain largement reconnu en matière de réduction de la charge tumorale, de survie des patients et d’amélioration de leur qualité de vie, dans un certain nombre de cancers. Hélas, ces thérapies exercent un effet immunosuppresseur en détruisant les effecteurs...

Full description

Bibliographic Details
Main Author:	Zoubir, Mustapha
Other Authors:	Paris 11
Language:	fr
Published:	2012
Subjects:	Immunosurveillance Traitement anticancéreux TLR Cellules dendritiques Cancer Herpes Inhibiteur de cycline kinase Imatinib mesylate Cyclophosphamide Cellules Th17 Anticancer drugs Dendritic cells CDK inhibitors Th17 cells
Online Access:	http://www.theses.fr/2012PA11T016

Similar Items

Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene[S]
by: Tara Ann Burns, et al.
Published: (2013-03-01)

Optimisation d’une stratégie thérapeutique antitumorale conventionnelle par association à une immunothérapie : etude de phase I combinant l’Imatinib à l’Interleukine-2
by: Locher, Clara
Published: (2013)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Prognosic Factors Related to The Complete Hematologic Response (CHR) in 3 Months in Leukemia Granulositic Patients Administered with Imatinib Mesylate
by: Ikhwan Rinaldi, et al.
Published: (2020-09-01)

Postoperative Cure for Metastatic Gastrointestinal Stromal Tumor
by: Eun Hyea Park, et al.
Published: (2018-12-01)

Management of a case of high-risk gastrointestinal stromal tumor in rectum by transanal minimal invasive surgery
by: Pramod Nepal, et al.
Published: (2018-08-01)

Effect of astaxanthin in imatinib mesylate-induced cardiotoxicity
by: İshak Suat Övey, et al.
Published: (2020-03-01)

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
by: Fabio Morandi, et al.
Published: (2018-09-01)

The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus Patients
by: Jiram Torres-Ruiz, et al.
Published: (2019-01-01)

An audit of gastrointestinal stromal tumors from a tertiary medical college hospital in Eastern India
by: Samrat Dutta, et al.
Published: (2018-01-01)

Renal phosphate loss in Iraqi chronic myeloid leukemia patients treated by imatinib mesylate
by: Huda A Al-Taee, et al.
Published: (2020-01-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

Falla cardiaca asociada con el uso de imatinib mesilato: Reporte de un caso Heart failure associated to imatinib mesylate use: Case report
by: Clara Saldarriaga, et al.
Published: (2008-12-01)

Assessment of fibrosis and vascularization of bone marrow stroma of chronic myeloid Leukemia patients treated with imatinib mesylate and their relationship with the cytogenetic response
by: Caroline Regina de Jesus, et al.
Published: (2011-06-01)

Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method
by: Ferdane Danışman Kalındemirtaş, et al.
Published: (2019-03-01)

Gastric Gastrointestinal Stromal Tumor with Repeated Recurrence at the Anastomosis Site in a Very Elderly Patient
by: Hye-Jin Kim, et al.
Published: (2020-10-01)

Generalized lichenoid drug eruption associated with imatinib mesylate therapy
by: Sudip Kumar Ghosh
Published: (2013-01-01)

Chronic subdural hematoma-unsual cause of headache in a patient with chronic myeloid leukemia treated with high-dose imatinib mesylate: A rare case report with review of literature
by: Sanjay M Khaladkar, et al.
Published: (2015-01-01)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
by: Chaoyong Shen, et al.
Published: (2014-11-01)

Successful Surgical Resection of Advanced Gastrointestinal Stromal Tumor Post Neoadjuvent Therapy
by: SM Kamil, et al.
Published: (2009-01-01)

by: P.B. Soares, et al.
Published: (2013-01-01)

In vitro inhibitory effects of imatinib mesylate on stromal cells and hematopoietic progenitors from bone marrow
by: P.B. Soares, et al.
Published: (2013-01-01)

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate
by: Vaneuza M. Funke, et al.
Published: (2008-04-01)

Une étude des voies de signalisation impliquées dans la carcinogénèse et le traitement des fibromatoses agressives
by: Dufresne, Armelle
Published: (2014)

Etude des effets du cyclophosphamide sur l’immunité anti-tumorale : relations avec le microbiote intestinal
by: Viaud, Sophie
Published: (2013)

Gastrointestinal stromal tumor of gastric origin: case report
by: Ayder Anselmo Gomes Vivi, et al.
Published: (2017-06-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

Prognostic factors associated with complete cytogenetic response in patients with chronic myelogenous leukemia on imatinib mesylate therapy
by: Ćojbašić Irena, et al.
Published: (2010-01-01)

Lack of Association of Multidrug Resistance Gene-1 Polymorphisms with Treatment Outcome in Chronic Myeloid Leukemia Patients Treated with Imatinib
by: Yaya Kassogue, et al.
Published: (2015-10-01)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013-08-01)

Primary Prostatic Extra-Gastrointestinal Stromal Tumor Treated with Imatinib Mesylate as Neoadjuvant and Adjuvant Therapy: A Case Report and Literature Review
by: Shen H, et al.
Published: (2019-12-01)

SÍNTESES E PROPRIEDADES DE FÁRMACOS INIBIDORES DA TIROSINA QUINASE BCR-ABL, UTILIZADOS NO TRATAMENTO DA LEUCEMIA MIELOIDE CRÔNICA
by: Liviane D. de Azevedo, et al.

Hepatic metastasis with heterologous rhabdomyoblastic differentiation in a patient with gastrointestinal stromal tumor treated with imatinib
by: Mukul Vij, et al.
Published: (2013-01-01)

Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
by: Ladislav Chrobák, et al.
Published: (2003-01-01)

OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01)

A rare case of eye complications of gastric stromal tumor treatment using imatinib mesylate
by: E. B. Myakoshina, et al.
Published: (2020-09-01)

Cellules dendritiques plasmacytoïdes et immunosurveillance ou échappement immunitaire dans le cancer du sein : impact des signaux activateurs versus inhibiteurs du microenvironnement tumoral
by: Vey, Nelly
Published: (2014)

CD8+XCR1neg Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors
by: Ben Wylie, et al.
Published: (2019-01-01)

Leucemia Mielóide Crônica em pediatria: perspectivas atuais Chronic Myeloid Leukemia in pediatrics patients: current approach
by: Maria Lucia M. Lee
Published: (2008-04-01)